Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05842057 · ClinicalTrials.gov registry record · Phase 2
Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy
A Phase 2 study of Prostate Cancer and Erectile Dysfunction Following Radical Prostatectomy, sponsored by University of Miami.
- Active
- Registry status
- Phase 2
- Development phase
- 118
- Enrollment target
- 1
- Study location
NCT05842057 is a Phase 2 study of Prostate Cancer and Erectile Dysfunction Following Radical Prostatectomy that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 118 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05842057, a Phase 2 study of Prostate Cancer and Erectile Dysfunction Following Radical Prostatectomy, is active but no longer recruiting, sponsored by University of Miami.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate if placing a dehydrated human amnion chorion membrane (dHACM) over the nerves after removal of the prostate during surgery (radical prostatectomy) will allow an earlier recovery of erectile function and urinary control after surgery.
Conditions Studied
Interventions
- PROCEDURE Robot-Assisted Radical Prostatectomy
- BIOLOGICAL BioDFence G3 Placental Tissue Membrane
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2023-08-24 |
| Est. Completion | 2028-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05842057
The ClinicalTrials.gov registry entry for NCT05842057 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (81% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Robot-Assisted Radical Prostatectomy is the first listed.
NCT05842057 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05842057 about?
NCT05842057 is a clinical study titled "Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy". The purpose of this research study is to evaluate if placing a dehydrated human amnion chorion membrane (dHACM) over the nerves after removal of the prostate during surgery (radical prostatectomy) will allow an earlier recovery of erectile function and urinary control after surgery.
What is the current status of trial NCT05842057?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 118 participants. The study started on 2023-08-24. Estimated completion is 2028-08-31.
What conditions does trial NCT05842057 study?
This clinical trial studies the following conditions: Prostate Cancer, Erectile Dysfunction Following Radical Prostatectomy.
What interventions are being tested in trial NCT05842057?
The interventions under investigation include: Robot-Assisted Radical Prostatectomy (PROCEDURE), BioDFence G3 Placental Tissue Membrane (BIOLOGICAL).
Who is sponsoring clinical trial NCT05842057?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05842057 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
RECRUITING · Phase 2
-
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
RECRUITING · Phase 2
-
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
RECRUITING · Phase 2
-
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging
RECRUITING · Phase 2
-
High Intensity Focused Ultrasound in Prostate Cancer
RECRUITING · Phase 2
Explore more on PlainTrial
Prostate Cancer
All registered trials for this condition
Erectile Dysfunction Following Radical Prostatectomy
All registered trials for this condition
Florida
All trials with a study site in Florida
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.